Receptor Activator Of Nuclear Factor Kappa-b Ligand
Receptor Activator Of Nuclear Factor Kappa-b Ligand - Related Videos
08:26
A Simple and Efficient Method to Detect Nuclear Factor Activation in Human Neutrophils by Flow Cytometry
0 Views •
Cited by 23 •
2013
Neutrophils are the most abundant leukocytes in blood. Neutrophils possess transcriptionally regulated functions such as production of proinflammatory cytokines and inhibition of apoptosis. These functions can be studied with the method presented here, which allows detection and quantification of nuclear factors by flow cytometry in isolated...
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
0 Views •
Cited by 6 •
2013
Ketoconazole binds to and antagonizes Pregnane X Receptor (PXR) activation. Yeast high throughput screens of PXR mutants define a unique region for ketoconazole binding. This yeast-based genetic method discovers novel nuclear receptor interactions with ligands that associate with surface binding sites.
10:24
Detection of Ligand-activated G Protein-coupled Receptor Internalization by Confocal Microscopy
0 Views •
Cited by 2 •
2017
This protocol describes confocal microscopy detection of G protein-coupled receptor (GPCR) internalization in mammalian cells. It includes the basic cell culture, transfection, and confocal microscopy procedure and provides an efficient and easily interpretable method to detect the subcellular localization and internalization of fusion-expressed GPCR.
12:38
Titration ELISA as a Method to Determine the Dissociation Constant of Receptor Ligand Interaction
0 Views •
Cited by 29 •
2018
A detailed protocol to perform a titration ELISA is described. Moreover, a novel algorithm is presented to evaluate titration ELISAs and to obtain a dissociation constant of binding of a soluble ligand to a microtiter plate-immobilized receptor.
05:57
Biomembrane Force Probe to Quantitate Receptor-Ligand Interactions
0 Views •
2025
In this video, biomembrane force probes (BFPs) are used to measure the forces between receptors and ligands. This technique can detect interactions by monitoring the pressure needed to break the bonds between the pMHC conjugated on the probe beads and the TCRs on the target cells.
FAQs
Binding of RANKL to RANK initiates intracellular signaling that shifts osteoclast precursor cells toward differentiation and maturation. NF-κB is one of the pathways activated during this process, linking receptor engagement to the development of cells capable of bone-resorbing activity. This mechanism explains how a molecular signal can connect cellular communication with changes in bone remodeling.
The balance between RANKL and osteoprotegerin helps determine how strongly this signaling axis operates. Osteoprotegerin can bind RANKL as a decoy receptor, limiting access to RANK and thereby restraining downstream effects on osteoclast precursors. This regulatory relationship is important because altered control of the interaction may help explain excessive osteoclast activity and inflammatory bone loss.
The axis provides a way to examine how immune communication and inflammatory signals influence bone remodeling. Because these signals can affect host responses as well as osteoclast-related activity, the pathway links immune processes with skeletal changes. This connection makes it relevant when studying how inflammation contributes to bone loss in immunological and infection-related contexts.
Studying RANKL, RANK, osteoprotegerin, and associated NF-κB signaling can clarify how extracellular communication produces cellular and tissue-level outcomes. Researchers can relate pathway activity to osteoclast differentiation, maturation, and bone-resorbing activity, while also considering immune communication. This supports a more integrated interpretation of interactions between inflammatory regulation and bone remodeling.
The pathway helps connect excessive osteoclast activity with conditions in which bone remodeling becomes clinically important. Signals that promote osteoclast differentiation, maturation, or bone-resorbing activity may contribute to skeletal loss, while osteoprotegerin provides a limiting mechanism. Consequently, the axis offers a framework for investigating both osteoporosis and bone damage associated with inflammation.
Targeting this signaling axis may help address excessive osteoclast activity by influencing the interaction among RANKL, RANK, and osteoprotegerin. The rationale follows from the pathway’s role in osteoclast development and bone-resorbing function. In research, this makes the axis useful for exploring therapeutic strategies intended to moderate abnormal bone loss while considering its connections to immune regulation.